Li Watsek

Cantor Fitzgerald

Li Watsek is an analyst from Cantor Fitzgerald Ranked #133 out of 4773 analysts, they have issued 6 stock ratings with a success rate of 100.00% and an average return of 68.14%.

With 6 ratings to date, Li Watsek is beginning to establish credibility in the market sector. They have achieved a success rate of 100.00% and an average return of 68.14%, highlighting promising potential as their track record develops further.

#133

Out of 4773

6

Total Ratings

+100.00%

Success Rate

+68.14%

Average Return

Recent Ratings Analysis

ZLAB

Feb 27, 2026

Target

$55.00

Current

$24.14

Performance

25.60%

Li Watsek rated ZLAB as Overweight on Feb 27, 2026, setting a price target of 55. The call has proven timely, with shares rising 25.60% toward the price target of 55.

TYRA

Feb 24, 2026

Target

—

Current

$22.03

Performance

-34.98%

On Feb 24, 2026, TYRA was given a Overweight rating by Li Watsek, with a target price of null. Despite the Buy call, shares fell from 22.03 to 22.03, challenging the optimistic stance.

AVBP

Dec 23, 2025

Target

—

Current

$29.00

Performance

29.93%

AVBP received a Overweight rating from Li Watsek on Dec 23, 2025, aiming for null. Momentum has favored the Buy call, with shares climbing from 29 to 29, rewarding those who trusted the recommendation.

CMPX

Dec 03, 2025

Target

—

Current

$2.00

Performance

-62.12%

On Dec 03, 2025, Li Watsek published a Overweight outlook on CMPX, with a target of null. Market action contradicted the Buy thesis, as shares slipped to 2.

ASND

Oct 13, 2025

Target

$254.00

Current

$263.51

Performance

26.43%

Li Watsek on Oct 13, 2025 assigned ASND a Overweight rating, with a price target of 254. The Buy call aligned well with market performance, producing a gain of 26.43%.

CNTX

Oct 02, 2025

Target

—

Current

$0.35

Performance

-64.95%

On Oct 02, 2025, Li Watsek reaffirmed CNTX with a Overweight rating, targeting null. Shares slid 64.95% despite the recommendation, highlighting downside risks.

IDYA

Sep 09, 2025

Target

—

Current

$37.59

Performance

51.94%

IDYA was rated Overweight by Li Watsek on Sep 09, 2025, with a price objective of null. A bullish response from the market helped close the gap of -37.59 to the target.

REPL

Jul 30, 2025

Target

—

Current

$12.92

Performance

71.13%

On Jul 30, 2025, Li Watsek initiated coverage on REPL with a Overweight rating and target of null. The stock’s climb of 71.13% since the call highlights the foresight in the rating.

KURA

Jun 26, 2025

Target

—

Current

$11.39

Performance

98.78%

Li Watsek issued a Overweight recommendation for KURA on Jun 26, 2025, price target set at null. Investors following the Buy call captured upside momentum, with shares now at 11.39.

ACRV

Mar 26, 2025

Target

—

Current

$2.00

Performance

-23.37%

On Mar 26, 2025, ACRV was evaluated by Li Watsek, who gave a Overweight rating and target of null. Investors saw limited payoff as shares fell short of the null target.

TARA

Mar 14, 2025

Target

—

Current

$3.82

Performance

-11.37%

Li Watsek rated TARA as Overweight on Mar 14, 2025, setting a price target of null. The stock has underperformed, dropping 11.37% despite the bullish target of null.

ARVN

Feb 07, 2025

Target

—

Current

$8.45

Performance

-54.81%

On Feb 07, 2025, ARVN was given a Overweight rating by Li Watsek, with a target price of null. Despite the Buy call, shares fell from 8.45 to 8.45, challenging the optimistic stance.

ALXO

Jan 24, 2025

Target

—

Current

$1.94

Performance

27.63%

ALXO received a Overweight rating from Li Watsek on Jan 24, 2025, aiming for null. Momentum has favored the Buy call, with shares climbing from 1.94 to 1.94, rewarding those who trusted the recommendation.

AFMD

Nov 19, 2024

Target

—

Current

$0.18

Performance

-93.95%

On Nov 19, 2024, Li Watsek published a Overweight outlook on AFMD, with a target of null. Market action contradicted the Buy thesis, as shares slipped to 0.1815.

RCUS

Oct 07, 2024

Target

—

Current

$24.59

Performance

42.14%

Li Watsek on Oct 07, 2024 assigned RCUS a Overweight rating, with a price target of null. The Buy call aligned well with market performance, producing a gain of 42.14%.

YMAB

Aug 16, 2024

Target

$20.00

Current

$8.61

Performance

-29.66%

On Aug 16, 2024, Li Watsek reaffirmed YMAB with a Overweight rating, targeting 20. Shares slid 29.66% despite the recommendation, highlighting downside risks.

Frequency Asked Questions

Who is Li Watsek?

Li Watsek is an analyst from Cantor Fitzgerald.

What is Li Watsek's success rate?

Li Watsek currently has a success rate of +100.00%.

How many ratings has Li Watsek issued?

Li Watsek has issued 6 stock ratings so far.

What is the average return of Li Watsek's calls?

Their stock ratings have generated an average return of +68.14%.

What is Li Watsek's ranking?

Li Watsek is ranked #133 out of 4773 analysts.

What types of ratings does Li Watsek give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Li Watsek?

You can follow Li Watsek by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Li Watsek?

Their latest rating was a Buy on ZLAB issued on 2026-02-27.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep